How CONSORT is Funded

By and large, the work of the CONSORT initiative has been moving forward through the in-kind contributions of experts around the world who comprise the CONSORT Group. Without them, there would have been little progress made in the development of this evidence-based reporting guideline. 

CONSORT receives some limited funding to support part-time administrative, coordination and research work, including two part-time CONSORT staff. This funding is greatly appreciated by the CONSORT Group, and has enabled some aspects of the work to be funded that was never before formally supported. The history of CONSORT funding is as follows:

One-time sources of funding have been obtained for specific meetings (see below) of the CONSORT Group, especially when focused on a specific issue (e.g., the reporting of harms). Sponsors for these meetings have recognized their importance in the inherently collaborative process of developing the CONSORT Statement. 

Even with this funding, however, there is still a long way to go for CONSORT to be self-sustaining. Despite continual efforts of the CONSORT executive to secure much-needed financial support, the current regular and one-time sources of funding do not fully support the ongoing activities of CONSORT. The advancement of the CONSORT initiative continues to reply heavily on the in-kind contributions of individuals who have taken a keen interest in contributing.

You can support CONSORT here.

We gratefully acknowledge these organizations and individuals for their financial support of the following CONSORT activities:

CONSORT Group Meeting 2011

  • President’s Fund - Canadian Institutes of Health Research
  • Johnson & Johnson
  • Pfizer USA
  • AstraZeneca
  • GlaxoSmithKline

CONSORT Group Meeting 2007

  • UK National Co-ordinating Centre for Research Methodology
  • American Society of Clinical Oncology
  • Canadian Institutes of Health Research
  • Johnson & Johnson
  • BMJ
  • UK Cochrane Centre
  • Nordic Cochrane Centre
  • The Lancet
  • PLoS Medicine

CONSORT Group Meetings 1999 and 2000

  • Abbott Laboratories
  • American College of Physicians/American Society of Internal Medicine
  • GlaxoWellcome, Inc. (now part of SmithKline Beecham, Inc.)
  • The Lancet
  • Merck & Co., Inc.
  • Canadian Institutes of Health Research
  • National Library of Medicine
  • TAP Pharmaceutical Products, Inc.
  • BMJ
  • Council of Science Editors
  • International Committee of Medical Journal Editors (Vancouver Group)